Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
PIPF 031: A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Trial ID or NCT#
This is an open label multi-center program to allow patients in the US with IPF access to treatment with pirfenidone.
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToTal Alfasi
Go Back To The Trial